CareDx, Inc. (CDNA)
77.88
-1.93
(-2.42%)
USD |
NASDAQ |
Nov 13, 16:00
77.00
-0.88
(-1.13%)
After-Hours: 19:59
CareDx EPS Diluted (Quarterly) : 0.3509 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.3509 |
| June 30, 2026 | 2.071 |
| March 31, 2026 | 0.0529 |
| December 31, 2025 | -0.0804 |
| September 30, 2025 | 0.0312 |
| June 30, 2025 | -0.1578 |
| March 31, 2025 | -0.1873 |
| December 31, 2024 | 1.506 |
| September 30, 2024 | -0.2011 |
| June 30, 2024 | -0.0886 |
| March 31, 2024 | -0.3847 |
| December 31, 2023 | -2.212 |
| September 30, 2023 | -0.4335 |
| June 30, 2023 | -0.4634 |
| March 31, 2023 | -0.4427 |
| December 31, 2022 | -0.3424 |
| September 30, 2022 | -0.3167 |
| June 30, 2022 | -0.4075 |
| March 31, 2022 | -0.3706 |
| December 31, 2021 | -0.3056 |
| September 30, 2021 | -0.2258 |
| June 30, 2021 | -0.0369 |
| March 31, 2021 | -0.0134 |
| December 31, 2020 | -0.0713 |
| September 30, 2020 | -0.0575 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.1467 |
| March 31, 2020 | -0.136 |
| December 31, 2019 | -0.1125 |
| September 30, 2019 | -0.0428 |
| June 30, 2019 | -0.1862 |
| March 31, 2019 | -0.181 |
| December 31, 2018 | -0.0936 |
| September 30, 2018 | -0.5375 |
| June 30, 2018 | -0.40 |
| March 31, 2018 | -0.30 |
| December 31, 2017 | -1.13 |
| September 30, 2017 | -0.63 |
| June 30, 2017 | -0.19 |
| March 31, 2017 | -0.26 |
| December 31, 2016 | -0.73 |
| September 30, 2016 | -0.26 |
| June 30, 2016 | -0.77 |
| March 31, 2016 | -0.81 |
| December 31, 2015 | -0.40 |
| September 30, 2015 | -0.29 |
| June 30, 2015 | -0.27 |
| March 31, 2015 | -0.19 |
| December 31, 2014 | -0.0004 |
| September 30, 2014 | 0.12 |
| June 30, 2014 | 0.0733 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Natera, Inc. | -0.4159 |
| Myriad Genetics, Inc. | -0.4587 |
| BioRestorative Therapies, Inc. | -2.431 |
| Exagen, Inc. | -0.255 |
| Sera Prognostics, Inc. | -0.1586 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.29M |
| Revenue (Quarterly) | 139.36M |
| Total Expenses (Quarterly) | 120.07M |
| Enterprise Value | 3.864B |
| Gross Profit Margin (Quarterly) | 70.51% |
| Profit Margin (Quarterly) | 13.84% |
| Earnings Yield | 3.07% |
| Operating Earnings Yield | 0.10% |
| Normalized Earnings Yield | 3.087 |